OUR INVESTORS

Financing Events:

​

Series D financing round of 13 MUSD was completed in Sept 2017 and led by Forrestal Capital

Series C financing round of 10 MUSD was completed in May 2016 and led by Integer Inc. (NYSE: INT)

Series B financing round of 8 MUSD was completed in September 2014.

Series A financing round of 14 MUSD was completed in April 2012.

Main investors are:

​

• BiomedInvest II, managed by BioMedPartners in Basel, Switzerland (www.biomedvc.com)

• BB Biotech Ventures III, managed by BB Biotech in Kuesnacht, Switzerland (www.bbbiotechventures.com)

• Initiative Capital Romandie, managed by Defi Gestion in Lausanne, Switzerland (www.defigestion.com)

• BV5 FPCI, managed by Kreaxi in Paris, France (http://www.kreaxi.com/en/)

• Integer Inc. (NYSE: INT) (www.integer.net)